NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 74 filers reported holding NEURODERM LTD in Q2 2017. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $37,000 | -88.9% | 950 | -91.4% | 0.00% | – |
| Q2 2017 | $332,000 | -55.5% | 11,082 | -60.5% | 0.00% | – |
| Q1 2017 | $746,000 | +15.5% | 28,078 | -3.2% | 0.00% | – |
| Q4 2016 | $646,000 | +131.5% | 28,998 | +92.0% | 0.00% | – |
| Q3 2016 | $279,000 | -2.8% | 15,104 | -14.6% | 0.00% | – |
| Q2 2016 | $287,000 | +12.1% | 17,682 | -2.2% | 0.00% | – |
| Q1 2016 | $256,000 | -71.4% | 18,081 | -65.5% | 0.00% | – |
| Q4 2015 | $895,000 | +29.0% | 52,472 | +56.3% | 0.00% | – |
| Q3 2015 | $694,000 | +455.2% | 33,562 | +314.6% | 0.00% | – |
| Q2 2015 | $125,000 | +190.7% | 8,095 | +153.0% | 0.00% | – |
| Q1 2015 | $43,000 | -66.9% | 3,200 | -65.5% | 0.00% | – |
| Q4 2014 | $130,000 | – | 9,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 327,240 | $9,784,000 | 4.26% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,383,358 | $131,062,000 | 2.70% |
| SENZAR ASSET MANAGEMENT, LLC | 357,400 | $10,686,000 | 2.63% |
| Rhenman & Partners Asset Management AB | 461,654 | $13,803,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 168,025 | $5,007,000 | 1.90% |
| GREAT POINT PARTNERS LLC | 311,000 | $9,299,000 | 1.67% |
| Opaleye Management Inc. | 120,300 | $3,597,000 | 1.50% |
| SECTORAL ASSET MANAGEMENT INC | 350,085 | $10,468,000 | 1.14% |
| MENORA MIVTACHIM HOLDINGS LTD. | 808,073 | $24,161,000 | 1.13% |
| Redmile Group, LLC | 555,096 | $16,597,000 | 1.01% |